Paul D. Burgess
CIK 1744627 · See Remarks · last filed 2026-04-20
Paul D. Burgess is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for KLRA, was dated Apr 20, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
10
-$2.23M
Holdings By Company
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | KLRA | Grant (A) | — | $0 | EDGAR |
| 2024-08-05 | — | Disp (D) | −45,727 | $0 | |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Exer (M) | +23,847 | $0 | EDGAR |
| 2023-08-07 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Buy (P) | +21,880 | $501.8K | EDGAR |
| 2023-07-06 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-14 | TBIO | Sell (S) | −71,833 | -$2.73M | EDGAR |
| 2021-03-09 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2020-03-05 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2019-03-12 | TBIO | Grant (A) | — | $0 | EDGAR |